4.6 Review

Anti-Infectious Agents against MRSA

期刊

MOLECULES
卷 18, 期 1, 页码 204-224

出版社

MDPI
DOI: 10.3390/molecules18010204

关键词

MRSA; anti-infectious agents; peptidoglycan; teichoic acid; virulence factors

资金

  1. Uehara Memorial Foundation
  2. Takeda Science Foundation
  3. Ministry of Education, Culture, Sports, Science, and Technology of Japan [21310146, 23790020]
  4. Grants-in-Aid for Scientific Research [21310146, 23790020] Funding Source: KAKEN

向作者/读者索取更多资源

Clinically useful antibiotics, beta-lactams and vancomycin, are known to inhibit bacterial cell wall peptidoglycan synthesis. Methicillin-resistant Staphylococcus aureus (MRSA) has a unique cell wall structure consisting of peptidoglycan and wall teichoic acid. In recent years, new anti-infectious agents (spirohexaline, tripropeptin C, DMPI, CDFI, cyslabdan, 1835F03, and BPH-652) targeting MRSA cell wall biosynthesis have been discovered using unique screening methods. These agents were found to inhibit important enzymes involved in cell wall biosynthesis such as undecaprenyl pyrophosphate (UPP) synthase, FemA, flippase, or UPP phosphatase. In this review, the discovery, the mechanism of action, and the future of these anti-infectious agents are described.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据